Join 60,000+ competitive exam aspirants
or with email
Your Cart
Subtotal₹0
Total₹0
Examoogle • User • info@examoogle.com • EE-2024-8821
Chapter 1 of 12 • Page 1 of 248🔒 Protected PDF • Watermarked
Join 60,000+ competitive exam aspirants
Awiqli (insulin icodec), the world’s first once-weekly basal insulin, has been introduced by which country?
India
France
Australia
New Zealand
India
India launched Awiqli, the world’s first once-weekly basal insulin.
India's introduction of Awiqli, also known as insulin icodec, marks a significant development in the treatment of diabetes. With over 101 million individuals suffering from diabetes in India, this innovation aims to simplify diabetes management by reducing the frequency of insulin injections from daily to weekly. The product, launched by Novo Nordisk, showed better diabetes control metrics like HbA1c reduction and improved Time in Range compared to existing daily treatments. This launch is pivotal in enhancing patient adherence and reducing the psychological burden of diabetes management.
Launched by Novo Nordisk in India in 2026
Awiqli reduces injections from 365 to 52 per year
Clinical trials showed improved HbA1c reduction
India has over 101 million diabetic patients
A is correct — India launched Awiqli, the world’s first once-weekly basal insulin, to ease diabetes management.
Remember the global impact of India's pharmaceutical industry; just as India is a major vaccine producer, it also innovates in diabetes treatments with leading-edge products like Awiqli.
Get instant step-by-step AI explanations, full shift Previous Year Papers (SSC GD, RRB, SSC JE), and regional rank analysis on the official Examoogle App.
Free Download • 100K+ Aspirants